Drug Price Trends for FT ANTACID EX-STR

Average Pharmacy Cost for FT ANTACID EX-STR

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FT ANTACID EX-STR 750 MG CHEW	70677-1076-01	0.03230	EACH	2024-12-18
FT ANTACID EX-STR 750 MG CHEW	70677-1079-01	0.03230	EACH	2024-12-18
FT ANTACID EX-STR 750 MG CHEW	70677-1076-01	0.03264	EACH	2024-11-20
FT ANTACID EX-STR 750 MG CHEW	70677-1079-01	0.03264	EACH	2024-11-20
FT ANTACID EX-STR 750 MG CHEW	70677-1079-01	0.03299	EACH	2024-10-23
FT ANTACID EX-STR 750 MG CHEW	70677-1076-01	0.03299	EACH	2024-10-23

Antacids Market Analysis and Price Projections

The antacids market, which includes products like FT ANTACID EX-STR, is poised for significant growth driven by several key factors. Here’s a comprehensive analysis of the market and its projections.

Global Antacids Market Size and Growth

The global antacids market is expected to experience substantial growth over the next decade. As of 2023, the market size is valued at approximately USD 14 billion and is projected to reach USD 22 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 4.6%[3].

Regional Market Dynamics

North America

North America is anticipated to hold a significant share of the antacids market. The region's dominance is attributed to the increasing incidence of gastroesophageal reflux disease (GERD) and other gastrointestinal issues among the population. The trend towards self-medication and the approval of new products, such as the FDA approval of Famotidine tablets by Zydus Lifesciences in 2022, further boost the market[1][4].

Asia Pacific

The Asia Pacific region is expected to be the fastest-growing segment, driven by significant unmet clinical needs, the availability of effective treatment modalities, and higher consumer awareness. This region's growth is also supported by the presence of prominent pharmaceutical companies[4].

Key Drivers of the Market

Rising Incidence of GERD and Gastrointestinal Issues

The increasing prevalence of GERD and other gastrointestinal disorders, particularly among the geriatric population, is a major driver of the antacids market. The elderly are more susceptible to peptic ulcers and GERD, which increases the demand for antacids[3][4].

Growing Awareness of Digestive Health

There is a growing awareness about digestive health, which is driving the consumption of antacids. This awareness, coupled with the rising consumption of processed and fast foods, contributes to the market's expansion[4].

Online Sales and Distribution

The sales of antacids through online pharmacies are expected to increase at a CAGR of 5% over the forecast period. High penetration of smartphones and improvements in telecom services are driving this trend[3].

Market Segmentation

By Drug Class

The antacids market is segmented by drug class into Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, and Acid Neutralizers. PPIs hold the maximum share of the market due to their effectiveness in reducing stomach acid production[4].

By Formulation Type

Antacids are available in various formulations, including tablets, liquids, and powders. Tablets account for a significant share of the global market, with around 50% of the market share in 2023[3].

By Distribution Channel

The market is segmented by distribution channels into retail pharmacies, hospital pharmacies, and online pharmacies. Online pharmacies are gaining traction due to the convenience and accessibility they offer[4].

Price Projections and Market Trends

Market Size Projections

By 2032, the global antacids market is expected to reach USD 10.9 billion, growing at a CAGR of 4.8% from 2024 to 2032[4].

Pricing Factors

The prices of antacids can be influenced by several factors, including production costs, regulatory approvals, and market competition. During the COVID-19 pandemic, prices were higher due to production and labor shortages, but the market saw favorable growth due to increased demand for gastrointestinal medications[1].

Competitive Landscape

The market is moderately concentrated with key players such as Sun Pharmaceuticals Ltd, Reckitt Benckiser Group plc, GlaxoSmithKline plc, Pfizer Inc., Bayer AG, and others. These companies are investing heavily in research and development and expanding their product portfolios to capture a larger market share[4].

Impact of COVID-19

The COVID-19 pandemic had a dual impact on the antacids market. On one hand, it led to production and labor shortages, resulting in higher prices. On the other hand, the pandemic increased the demand for gastrointestinal medications, including antacids, as these were found to be beneficial in treating COVID-19 patients with acidosis-related conditions[1].

"Acidosis-related pH promoted SARS-CoV-2 infection and suggested the existence of a positive feedback loop in which SARS-CoV-2 infection-induced acidosis enhances SARS-CoV-2 infection. Therefore, antacid therapy for acidosis COVID-19 patients was necessary during the pandemic."[1]

Key Takeaways

• The global antacids market is expected to grow significantly, reaching USD 22 billion by 2033.
• North America and the Asia Pacific region are key markets, with the latter expected to be the fastest-growing segment.
• The rising incidence of GERD and gastrointestinal issues, especially among the geriatric population, is a major driver.
• Online sales and distribution channels are becoming increasingly important.
• The market is moderately concentrated with several key players investing in R&D and product expansion.

FAQs

What is the expected growth rate of the global antacids market?

The global antacids market is forecasted to grow at a CAGR of 4.6% from 2023 to 2033[3].

Which region is expected to be the fastest-growing segment in the antacids market?

The Asia Pacific region is projected to be the fastest-growing segment in the forecast years[4].

What are the main drivers of the antacids market?

The main drivers include the rising incidence of GERD and gastrointestinal issues, growing awareness of digestive health, and increasing online sales[3][4].

Which drug class holds the maximum share of the antacids market?

Proton Pump Inhibitors (PPIs) hold the maximum share of the antacids market due to their effectiveness[4].

How did the COVID-19 pandemic impact the antacids market?

The pandemic led to higher prices due to production and labor shortages but also increased demand for gastrointestinal medications, including antacids[1].

What is the projected market size of the antacids market by 2032?

The global antacids market is expected to reach USD 10.9 billion by 2032[4].

Sources

1. Mordor Intelligence: Antacids Market Report | Industry Analysis, Size & Forecast Overview
2. Fact.MR: Antacids Market Size, Share, Demand & Growth Analysis, 2033
3. Acumen Research and Consulting: Antacids Market Size, Share, Trends | Forecast 2032
4. TUMS: TUMS Ultra Strength 1000 mg Antacids for Heartburn Relief